Talk to a healthcare professionals 1-855-899-2873

Search

Advanced cancer

Blog

Our series of blog posts

Our blogs are written by health professionals who have expertise in the field of prostate and prostate cancer. You can therefore be assured that the information provided is precise and accurate. The many topics covered are intended to help people better understand the effects of the disease, treatment options and how to improve their quality of life.

#

Why should I participate in a clinical trial?

You may be comforted to know that doctors and scientists are working diligently at finding new and better ways to treat, prevent, and screen for prostate cancer as well as to enhance the quality of life for prostate cancer patients. This work is done through clinical trials. What is a clinical trial? After a new […]

Read the article
#

My Journey with an Advanced Prostate Cancer: The End of my Journey Counts

Counts It is difficult to address matters related to end of life. It is however an essential step, particularly with an advanced prostate cancer diagnosis.

Read the article
#

My Journey with an Advanced Prostate Cancer: My Relationships Count

A diagnosis of prostate cancer, mainly at an advanced stage, can modify your relationships with some people of your entourage.

Read the article
#

My Journey with an Advanced Prostate Cancer: What Is Counting for Me

Prostate cancer highly affects the quality of life of those who suffer from it, mainly at an advanced stage.

Read the article
#

Xofigo®: Quebec patients have access to a new treatment for prostate cancer

Men in Quebec are one step closer to accessing Xofigo, for the treatment of castration-resistant prostate cancer with symptomatic bone metastases and no known visceral metastatic disease, thanks to a recent announcement by the Quebec government.

Read the article
#

Health Canada Approves New Indication for Castration-Resistant Prostate Cancer

New Indication for the Use of Xtandi® (enzalutamide) Capsules Approval based on improved overall survival, delayed time to radiographic progression and an overall positive risk-benefit profile In the Phase III PREVAIL trial, men receiving enzalutamide therapy exhibited a statistically significant improvement in both overall survival and delayed time to radiographic progression or death as compared to […]

Read the article

Prostate cancer
do not experience it alone.

Our healthcare professionals are here to answer all your questions and those of your loved ones. Contact us.

7/7 toll-free support line

1-855-899-2873

Contact Us
© 2023 PROCURE – All rights reserved | Registration number: 86394 4955 RR0001

Terms of use | Privacy policy